Walter V Klemp Moleculin Biotech, Inc. (MBRX) insider trading activity

Walter V Klemp is CEO and President of Moleculin Biotech, Inc.. Currently has a direct ownership of 743,607 shares of MBRX, which is worth approximately $230,518. The most recent transaction as insider was on Nov 21, 2022, when has been sold 22,500 shares (Common Stock) at a price of $1.15 per share, resulting in proceeds of $25,874. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 744K

1203.77% 3M change

1220.96% 12M change

Total Value Held $230,518

WALTER V KLEMP Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 21 2022	BUY Open market or private purchase	$25,874 $1.15 p/Share	22,500 Added 5.81%	364,890 Common Stock
Nov 17 2022	BUY Open market or private purchase	$25,236 $1.02 p/Share	24,742 Added 6.74%	342,390 Common Stock
Nov 16 2022	BUY Open market or private purchase	$82,656 $0.97 p/Share	85,213 Added 21.15%	317,648 Common Stock
Jul 11 2022	SELL Payment of exercise price or tax liability	$5,401 $1.68 p/Share	3,215 Reduced 1.36%	232,435 Common Stock
Jul 11 2022	BUY Exercise of conversion of derivative security	-	13,204 Added 5.31%	235,650 Common Stock
Jul 02 2022	SELL Payment of exercise price or tax liability	$5,268 $1.47 p/Share	3,584 Reduced 1.59%	222,446 Common Stock
Jul 02 2022	BUY Exercise of conversion of derivative security	-	14,717 Added 6.11%	226,030 Common Stock
Jun 16 2022	SELL Payment of exercise price or tax liability	$8,097 $1.33 p/Share	6,088 Reduced 2.8%	211,313 Common Stock
Jun 16 2022	BUY Exercise of conversion of derivative security	-	25,000 Added 10.31%	217,401 Common Stock
Jul 11 2021	SELL Payment of exercise price or tax liability	$11,445 $3.56 p/Share	3,215 Reduced 1.64%	192,401 Common Stock
Jul 11 2021	BUY Exercise of conversion of derivative security	-	13,205 Added 6.32%	195,616 Common Stock
Jul 02 2021	SELL Payment of exercise price or tax liability	$12,759 $3.56 p/Share	3,584 Reduced 1.93%	182,411 Common Stock
Jul 02 2021	BUY Exercise of conversion of derivative security	-	14,718 Added 7.33%	185,995 Common Stock

Also insider at

AMIX

Autonomix Medical, Inc.

Director

WVK

Walter V Klemp

CEO and President

Houston, TX

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MBRX shares.

Notify only if

Value

Insider Trading

Get notified when an Moleculin Biotech, Inc. insider buys or sells MBRX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Moleculin Biotech, Inc.

Track Activities on MBRX

Account